Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
收藏官方服务：
资源简介：
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
应用场景：
创建时间：
2014-10-01
相关数据集
Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: a comparison between two tablet formulations of cephalexin
The aim of the present study was to assess the bioequivalence of two cephalexin tablet formulations available in the Brazilian market (product A as reference formulation and product B as test formulat
DataCite Commons2022-06-09 更新60
LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand
BACKGROUND: It is commonly agreed that people with a high blood LDL-cholesterol will have a higher risk of coronary artery disease (CAD) than people with low blood LDL-cholesterol. Due to the increasi
PubMed Central2002-01-30 更新10
Replication Data and Code for: Bayesian toxo-equivalence model between docetaxel and paclitaxel
Complete meta-analysis data on all studies used in our manuscript, "Development of a Bayesian toxo-equivalence model between docetaxel and paclitaxel: a systematic review and meta-analysis"
Harvard Dataverse2021-10-15 更新00
A study assessing the similarity of Avastin (Registered Trademark) and the trial drug DRL_BZ.
Interventions: Three Bevacizumab Preperations Arm 1: DRL_BZ 100 mg in 4 mL - 1mg/kg Recombinant humanised monoclonal antibody - bevacizumab 1 time only Intravenous infusion. Arm 2: Avastin (Registered
NIAID Data Ecosystem60
Dataset from Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt)and PARIET 20 mg DR Tabs (JANSSEN, EGYPT) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions
This is an open-label, randomized, single dose, two-sequence, two-period crossover study, separated by 7 days washout interval from the first study drug administration. In this study, the bioavailabil
NIAID Data Ecosystem00
